| Abstract | One gram once daily of ceftriaxone is as effective as 2 gm for the common causative organisms of community-acquired and nosocomial pneumonias. It should not be used alone against L. pneumophila, the TWAR pneumoniae, and possibly anaerobic pathogens. Preliminary study suggests that a regimen of 500 mg a day may be effective in selected patients with simple pneumonias caused by sensitive pathogens. Ceftriaxone is safe, well tolerated, and cost-effective, which means it can play a significant therapeutic role in nursing homes and other long-term care facilities as well as in outpatient therapy. |
| Authors | R Brown
(Affiliation: Tufts University, Boston, Mass.)
|
| Journal | Hospital practice (Office ed.)
(Hosp Pract (Off Ed))
Vol. 26 Suppl 5
Pg. 37-42; discussion 59-62
(Sep 1991)
ISSN: 8750-2836 UNITED STATES |
| PMID | 1918221
(Publication Type: Journal Article, Review)
|
| Chemical References |
|
| Topics |
- Bacterial Infections
(drug therapy)
- Ceftriaxone
(administration & dosage, therapeutic use)
- Drug Administration Schedule
- Humans
- Pneumonia
(drug therapy)
- Respiratory Tract Infections
(drug therapy)
|
